Cibc Private Wealth Group, LLC Beam Therapeutics Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,047 shares of BEAM stock, worth $46,548. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,047
Previous 1,981
3.33%
Holding current value
$46,548
Previous $49,000
20.41%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BEAM
# of Institutions
249Shares Held
95.7MCall Options Held
666KPut Options Held
1.99M-
Farallon Capital Management LLC San Francisco, CA10MShares$228 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.71MShares$221 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.85MShares$201 Million1.24% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$174 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$110 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.6B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...